Patents Assigned to Pharmuka Laboratoires
  • Patent number: 4613607
    Abstract: Antiarhythmic medicaments containing, as active substance, a compound of the formula: ##STR1## in which n is 1 or 2, X and Y are fixed in positions 5, 6, 7 or 8 on the quinoline cycle and each represents a hydrogen atom or an alkoxy group having 1 to 3 carbons, R is a hydrogen atom or an alkyl group having 1 to 4 carbons, cycloalkyl having 3 to 8 carbons, phenyl or phenyl substituted by alkoxy having 1 to 4 carbons, R.sub.1 is a hydrogen atom or an alkyl group having 1 to 4 carbons or a phenylalkyl group of which the alkyl part has 1 to 3 carbons, R.sub.2 is a hydrogen atom, an alkyl group having 1 to 2 carbons or an alkenyl group having 2 to 4 carbons.
    Type: Grant
    Filed: September 30, 1983
    Date of Patent: September 23, 1986
    Assignee: Pharmuka Laboratoires
    Inventors: Claude G. A. Gueremy, Michel A. P. Mestre, Christian L. A. Renault
  • Patent number: 4590424
    Abstract: A detector of ion concentration in a liquid is composed of a detection cell comprising a tubular piece formed from an electrically insulating material with a central passage which is fed with a liquid whose ion concentration is to be measured. A conducting coil is placed around the tubular piece, and is part of a first resonant circuit. A second reference resonant circuit is also provided, and signals of fixed frequency are applied in parallel to the two resonant circuits, and a comparator delivers a signal having a magnitude representative of the difference between the output signals from the two resonant circuits. Such a detector finds a use for example in liquid chromatography.
    Type: Grant
    Filed: September 23, 1983
    Date of Patent: May 20, 1986
    Assignee: Pharmuka Laboratoires
    Inventors: Pierre Girot, Egisto Boschetti
  • Patent number: 4546185
    Abstract: Process for the preparation of compounds of the formula: ##STR1## in which X is H, Cl, Br, I or OH, in which 3-methylene quinuclidine is reacted with an aluminum hydride, in an appropriate solvent and in the presence of a catalytic quantity of a halide of a transition metal, the molar ratio ##EQU1## being at least equal to 0.6, the product formed is reacted in situ with an ester, and then the product thus formed is reacted in situ with an electrophilic reactant which is capable of yielding an atom or group X as defined with reference to formula (I). The compounds of formula (I) can be used for the preparation of medicaments.
    Type: Grant
    Filed: August 11, 1983
    Date of Patent: October 8, 1985
    Assignee: Pharmuka Laboratoires
    Inventors: Jean-Claude Bondiou, Francoise Hodac, Didier Legroux
  • Patent number: 4535080
    Abstract: Compounds are disclosed as useful as drugs or as intermediates for the manufacture of drugs, the compounds having the formula: ##STR1## in which X is hydrogen, chlorine, alkyl, alkoxy or alkylthio having 1 to 3 carbon atoms, R.sub.2 is hydrogen or alkyl having 1 to 3 carbon atoms, Y.sub.2 is chlorine and Y.sub.1 is chlorine or ##STR2## in which R.sub.1 is hydrogen, straight or branched chain alkyl having 1 to 7 carbon atoms, cycloalkyl having 3 to 7 carbon atoms or cycloalkylalkyl having 4 to 8 carbon atoms, or Y.sub.2 and Y.sub.1 are both OH. Also disclosed are methods for preparation of the compounds.
    Type: Grant
    Filed: August 24, 1983
    Date of Patent: August 13, 1985
    Assignee: Pharmuka Laboratoires
    Inventors: Francois Audiau, Claude G. A. Gueremy, Gerard R. Le Fur
  • Patent number: 4499094
    Abstract: Compounds with the formula: ##STR1## in which R.sub.1 and R.sub.2 represent independently, a linear or branched alkyl, cycloalkyl, phenylalkyl or cycloalkylalkyl group. R.sub.1 and R.sub.2 may also represent an alkenyl or alkynyl group. R.sub.1 and R.sub.2 may also represent a group of the formula --R.sub.3 --Z--R.sub.4 in which R.sub.3 represents an alkylene group, on condition that at least 2 carbon atoms separate the nitrogen atom from the group Z; R.sub.4 represents an alkyl group, and Z an atom of oxygen, sulphur or the group >N--R.sub.5, R.sub.5 representing a hydrogen atom or an alkyl group. R.sub.1 and R.sub.2 may form, with the nitrogen atom to which they are attached, a heterocyclic ring. Ar represents a phenyl, pyridyl or thienyl group, or a substituted phenyl group, A and B representing independently, N or CH--, the group C representing the residue of a benzene or thiophene ring. These compounds can be used as medicaments, in particular, for the various applications of benzodiazepines.
    Type: Grant
    Filed: April 5, 1983
    Date of Patent: February 12, 1985
    Assignee: Pharmuka Laboratoires
    Inventors: Marie-Christine Dubroeucq, Christian Renault, Gerard Le Fur
  • Patent number: 4478713
    Abstract: In the automatic installation for liquid chromatography according to the invention, the container of product to be fractionated is associated to a measuring container and is provided, as are the containers of eluents, with low level detector means; feed valves are interposed between said containers and the injection pump whereas output valves are interposed between the outlet from the column and the collector containers; a control unit comprises a safety device connected to the low level detectors to control the stoppage of the pump whenever necessary, and a control device receiving the signals from detection means connected to the output of the column and controlling the measuring container and said valves to perform successive cycles of chromatography each one including the steps of injecting a quantity of product, admitting at least one eluent and collecting the or each corresponding fraction.
    Type: Grant
    Filed: September 23, 1983
    Date of Patent: October 23, 1984
    Assignee: Pharmuka Laboratoires
    Inventors: Pierre Girot, Egisto Boschetti
  • Patent number: 4478841
    Abstract: Compounds of general formula: ##STR1## wherein X represents a hydrogen or halogen atom, R represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms and A represents the 1,2,5,6-tetrahydro-4-pyridyl or the 1,2,3,4,5,6-hexahydro-4-pyridyl radical, with the proviso that when A is the 1,2,3,4,5,6-hexahydro-4-pyridyl radical, R is alkyl having 1 to 3 carbon atoms, are disclosed together with methods for their preparation and their use in the treatment of migraines, as antithrombosis agents or as rapid acting thymoanaleptic medicaments.
    Type: Grant
    Filed: May 3, 1982
    Date of Patent: October 23, 1984
    Assignee: Pharmuka Laboratoires
    Inventors: Francois Audiau, Gerard R. Le Fur
  • Patent number: 4416898
    Abstract: A method for the treatment of degenerative diseases such as Parkinsonism and aging by the administration of a pharmaceutically effective amount of L-methionine or DL-methionine.
    Type: Grant
    Filed: March 1, 1982
    Date of Patent: November 22, 1983
    Assignee: Pharmuka Laboratoires
    Inventor: Gerard R. Le Fur